Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma-Reference-Cited by-同舟云学术

Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma

Published:1995-07 Issue:1 Volume:43 Page:123-127
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Eng Charls,Mulligan Lois M.,Smith Darrin P.,Healey Catherine S.,Frilling Andrea,Raue Friedhelm,Neumann Hartmut P.H.,Ponder Margaret A.,Ponder Bruce A.J.

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1995.tb01903.x/fullpdf

Reference20 articles.

1. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.

2. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC

3. Mutation of theRET protooncogene in sporadic medullary thyroid carcinoma

4. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Review of the Imaging Recommendations for Diagnosis, Staging, and Management of Thyroid Carcinoma;Journal of Clinical Medicine;2024-05-14

2. Medullary Thyroid Cancer;Neuroendocrine Tumours;2024

3. Medullary Thyroid Carcinoma;The Bethesda System for Reporting Thyroid Cytopathology;2023

4. Management of medullary carcinoma of the thyroid: a review;Journal of International Medical Research;2022-07

5. Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies;Cancer Treatment Reviews;2022-04